|Articles|August 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-08-02-2018
  • Volume 42
  • Issue 8

Advanced Paddle Blender for Labs

Ross, Charles & Son’s Laboratory Paddle Blender offers advanced features for automated powder blending and liquid spraying operation with recipe management.

Ross, Charles & Son’s Laboratory Paddle Blender offers advanced features for automated powder blending and liquid spraying operation with recipe management. Features include full vacuum capability, a pneumatic powder charging port, and a liquid delivery spray system to promote batch-to-batch consistency. The 1-ft3, 42P-1SS model is constructed entirely of United States stainless steel type 304 with 150-grit interior finish and driven by a 1-hp, totally enclosed, fan-cooled motor. 

Touchscreen programmable logic controller recipe controls are housed inside a National Electrical Manufacturers Association-classified 4X stainless steel enclosure, allowing for indoor or outdoor use. The company states that an interchangeable ribbon agitator can be supplied with any new paddle blender for increased versatility. Both paddle and ribbon agitators are used in the preparation of dry solid-solid mixes and can accommodate minor liquid additions.

Ross, Charles & Son


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.